HST Global (HSTC) 10-Q 4 Jun 24 2024 Q1 Quarterly report Financial data

Document and Entity Information

Document and Entity Information		3 Months Ended
	Mar. 31, 2024 shares	Mar. 31, 2024 shares
Details
Registrant CIK		0000797564
Fiscal Year End		--12-31
Entity Emerging Growth Company		true
Entity Small Business		true
Entity Ex Transition Period		false
Entity Shell Company		false
Document Type		10-Q
Document Period End Date		Mar. 31, 2024
Securities Act File Number		000-15303
Entity Registrant Name		HST Global, Inc.
Entity Incorporation, State or Country Code		NV
Entity Tax Identification Number		73-1215433
Entity Address, Address Line One		509 Old Great Neck Road
Entity Address, Address Line Two	Suite 105
Entity Address, City or Town		Virginia Beach
Entity Address, State or Province		VA
Entity Address, Postal Zip Code		23454
City Area Code		800
Local Phone Number		961-4750
Entity Current Reporting Status		Yes
Entity Interactive Data Current		Yes
Entity Filer Category		Non-accelerated Filer
Entity Common Stock, Shares Outstanding	5,248,582	5,248,582
Amendment Flag		false
Document Fiscal Year Focus		2024
Document Fiscal Period Focus		Q1
Document Quarterly Report		true
Document Transition Report		false

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current Assets
Cash and cash equivalents	$ 838	$ 1,526
Total Current Assets	838	1,526
Total Assets	838	1,526
Current Liabilities
Accounts payable and accrued expenses	2,275	2,275
Accounts payable and accrued expenses - related parties	510,000	480,000
Loans or advances from related party	100,319	98,319
Accrued related party interest	14,488	12,999
Total Current Liabilities	627,082	593,593
Total Liabilities	627,082	593,593
Stockholders' Deficit
Preferred stock; 10,000,000 shares authorized, at $0.001 par value, 0 shares issued and outstanding	0	0
Common stock; 200,000,000 shares authorized, at $0.001 par value, 5,248,582 shares issued and outstanding	5,248	5,248
Additional paid-in capital	5,417,236	5,417,236
Accumulated deficit	(6,048,728)	(6,014,551)
Total Stockholders' Deficit	(626,244)	(592,067)
Total Liabilities and Stockholders' Deficit	$ 838	$ 1,526

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Condensed Consolidated Statements of Operations
REVENUES	$ 0	$ 0
OPERATING EXPENSES
Consulting, related party	30,000	30,000
General and administrative	2,688	8,075
Total Operating Expenses	32,688	38,075
Loss from Operations	(32,688)	(38,075)
OTHER INCOME (EXPENSE)
Interest expense	1,489	1,211
Total Other Expense	(1,489)	(1,211)
Loss Before Income Taxes	(34,177)	(39,286)
Provision for Income Taxes	0	0
NET LOSS	$ (34,177)	$ (39,286)
Basic and Diluted Loss Per Share	$ (0.01)	$ (0.01)
Basic and Diluted Weighted Average Number of Common Shares Outstanding	5,248,582	5,248,582

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Deficit - USD ($)	3 Months Ended
	Mar. 30, 2024	Mar. 30, 2023	Mar. 31, 2023	Mar. 31, 2024
Common Stock
Balance, December 31, 2022			$ 5,248	$ 5,248
Net loss	$ 0	$ 0
Balance, March 31, 2023			5,248	5,248
Balance, December 31, 2023	5,248	5,248
Additional Paid-in Capital
Balance, December 31, 2022			5,417,236	5,417,236
Net loss	0	0
Balance, March 31, 2023			5,417,236	5,417,236
Balance, December 31, 2023	5,417,236	5,417,236
Retained Earnings
Balance, December 31, 2022			(5,907,627)	(6,048,728)
Net loss	(34,177)	(39,286)
Balance, March 31, 2023			(5,907,627)	(6,048,728)
Balance, December 31, 2023	(6,014,551)	(5,868,341)
Parent
Balance, December 31, 2022			(485,143)	(626,244)
Net loss	(34,177)	(39,286)
Balance, March 31, 2023			$ (485,143)	$ (626,244)
Balance, December 31, 2023	$ (592,067)	$ (445,857)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating Activities
Net loss	$ (34,177)	$ (39,286)
Changes in operating assets and liabilities
Accounts payable and accrued expenses	0	0
Accrued related party interest	1,489	1,212
Net Cash Used in Operating Activities	(32,688)	(38,075)
Investing Activities
Net Cash Used in Investing Activities	0	0
Financing Activities
Proceeds from loans or advances from related party	2,000	8,000
Accounts payable and accrued expenses-related parties	30,000	30,000
Net Cash Provided by Financing Activities	32,000	38,000
Net Change in Cash and Cash Equivalents	(688)	(75)
Cash and Cash Equivalents at Beginning of Period	1,526	190
Cash and Cash Equivalents at End of Period	838	115
Cash paid for interest	0	0
Cash paid for taxes	$ 0	$ 0

NOTE 1 - ORGANIZATION AND PRINC

NOTE 1 - ORGANIZATION AND PRINCIPAL ACTIVITIES	3 Months Ended
	Mar. 31, 2024
Notes
NOTE 1 - ORGANIZATION AND PRINCIPAL ACTIVITIES	NOTE 1 – ORGANIZATION AND PRINCIPAL ACTIVITIES HST Global, Inc. (the "Company") was incorporated on April 11, 1984 under the laws of the State of Delaware under the name of NT Holding Corporation. The Company made several acquisitions and disposals of various business entities and activities. On May 9, 2008, the Company entered into a Merger and share exchange agreement with Health Source Technologies, Inc. This business acquisition was accounted for as a reverse merger or recapitalization of Health Source Technologies, Inc. At the time of the merger NT Holding Corporation had disposed of its assets and liabilities and had minimal operations. Immediately after the acquisition the Company changed its name to HST Global, Inc. Health Source Technologies, Inc. was incorporated under the laws of the State of Nevada on August 6, 2007. The Company was headquartered in Hampton, VA on March 31, 2024 and is currently headquartered in Virginia Beach, Virginia. The Company was founded as an Integrated Health and Wellness Biotechnology company with a plan to develop and /or acquire a network of Wellness Centers worldwide that would be primarily focused on the homeopathic and alternative treatment of late stage cancer. The Company is a dynamic public holding company, strategically focused on the intersection of the Healthcare, Software, and Transportation industries. With a commitment to innovation and excellence, HST Global specializes in identifying potential investment opportunities and spearheading ventures within these critical sectors. Core Industries • Healthcare • Software • Transportation Investment Philosophy Vision and Mission Vision Mission The accompanying interim condensed financial statements have been prepared in accordance with the instructions to Form 10-Q pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and, therefore, do not include all information and footnotes necessary for a complete presentation of the Company’s financial position, results of operations, cash flows, and stockholders’ equity in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). In the opinion of management, all adjustments considered necessary for a fair presentation of the results of operations and financial position have been included and all such adjustments are of a normal recurring nature. The unaudited quarterly condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K of the Company as of and for the fiscal year ended December 31, 2023. The results of operations for the period ended March 31, 2024, are not necessarily indicative of the results for a full-year period.

NOTE 2 - SIGNIFICANT ACCOUNTING

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES	3 Months Ended
	Mar. 31, 2024
Notes
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying condensed financial statements and related notes include the activity of the Company and have been prepared in accordance with U.S. GAAP and with the rules and regulations of the SEC to Form 10-K and 10-Q. Accounting Method The Company’s condensed financial statements are prepared using the accrual method of accounting. The Company has elected a December 31 year-end. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents We maintain cash balances in non-interest-bearing accounts, which do not currently exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents. Basic and Diluted Loss Per Share The computations of basic loss per share of common stock are based on the weighted average number of shares outstanding at the date of the financial statements. The Company computes net loss per share in accordance with ASC 260, “ Earnings Per Share Stock-Based Compensation The Company adopted ASC 718, “Stock Compensation” values beginning in the period they are granted and amortized over the applicable vesting period. As of September 30, 2023, the Company has not issued any employer stock options. Fair Value of Financial Instruments The Company adopted ASC 820, “ Fair Value Measurement The Company currently does not have non-financial assets or non-financial liabilities that are required to be measured at fair value on a recurring basis.

NOTE 3 - GOING CONCERN

NOTE 3 - GOING CONCERN	3 Months Ended
	Mar. 31, 2024
Notes
NOTE 3 - GOING CONCERN	NOTE 3 – GOING CONCERN The Company’s condensed financial statements are prepared in accordance with U.S. GAAP applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern for a period of one year from the issuance of these financial statements. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. Management’s plan to support the Company in its operations and to maintain its business strategy is to raise funds through public offerings and to rely on officers and directors to perform essential functions with minimal compensation. If the Company does not raise all of the funds it needs from public offerings, it will have to find alternative sources, such as a second public offering, a private placement of securities, or loans from its officers, directors or others. If the Company requires additional cash and is unable to raise it, it will either have to suspend operations until the cash is raised, or cease business entirely. The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying condensed financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

NOTE 4 - RELATED PARTY TRANSACT

NOTE 4 - RELATED PARTY TRANSACTIONS	3 Months Ended
	Mar. 31, 2024
Notes
NOTE 4 - RELATED PARTY TRANSACTIONS	NOTE 4 – RELATED PARTY TRANSACTIONS Loans or Advances from Related Party During the three months ended March 31, 2024, the Company received $2,000 in additional cash loans from Ronald R. Howell. As of March 31, 2024, the Company owed Mr. Howell $100,319 in notes payable. As part of the reorganization on April 24, 2024, Mr. Howell cancelled all outstanding debt obligations owed to him which was a total of $624,808, including the notes payable referenced above. See “Change of Control”. Executive Offices The Company’s executive offices were located at 150 Research Dr., Hampton VA. These offices were leased by The Health Network, Inc. (“THN”), of which Ron Howell is President. Effective with the reorganization on April 24, 2024, the Company’s executive officers were moved to 509 Old Great Neck Road Suite 105 Virginia Beach, VA 23454. Consulting Agreements The Company entered into a consulting agreement with Mr. Howell, President of the Company, whereby the Company agreed to pay Mr. Howell $10,000 per month for consulting services through December 31, 2010. The Company had agreed to continue to engage Mr. Howell as a consultant until his consulting services are no longer required. As of March 31, 2024, the Company owed Mr. Howell $510,000 under the consulting agreement plus $14,488 in accumulated interest expenses. As part of the reorganization on April 24, 2024, Mr. Howell cancelled all outstanding debt obligations owed to him which was a total of $624,808, including the amounts and accumulated interest due under the consulting agreement referenced above. See “Change of Control”.

NOTE 5 - SUBSEQUENT EVENTS

NOTE 5 - SUBSEQUENT EVENTS	3 Months Ended
	Mar. 31, 2024
Notes
NOTE 5 - SUBSEQUENT EVENTS	NOTE 5 – SUBSEQUENT EVENTS Change of Control On April 24, 2024, HST Global, Inc., a Nevada Corporation (the “Company”) entered into a Reorganization and Stock Purchase Agreement (the “Reorganization Agreement”) by and among HP Auto Fund LLP (“HPAF”), HST Global Holdings, LLC (“HGHI”), Ron Howell (“Howell”) and The Health Network, Inc. (“Health Network”). Howell and Health Network were the principal shareholders of the Company. Effective April 26, 2024, the parties closed the Reorganization Agreement. As part of the transaction, Howell and Health Network, the then majority shareholders of the Company (the “the Company Shareholders”) delivered 1,634,738 shares of common stock of the Company to each of HPAF and HGHI. In addition, the Company issued to each of HPAF and HGHI 18,156,322 shares of newly-issued common stock, which, together with the transferred shares, represented approximately 95% of the outstanding equity of the Company. Further, as part of the transaction, Howell agreed to cancel $624,808 in debt obligations previously owed to Howell. As a consequence, immediately subsequent to the close of the Reorganization Agreement, the Company has 41,561,226 shares of common stock outstanding. Also as part of the reorganization, the Company will undertake a 1 for 10 reverse stock split of its outstanding shares effective upon approval by FINRA. Effective April 26, 2024 HSTC announced the appointment of Mike Field and Jason Murphy as Directors of the Company. Subsequently, the Directors appointed Mike Field as President and Acting CFO and Jason Murphy as CEO, Vice President and Secretary. In accordance with ASC 855, “Subsequent Events”

NOTE 2 - SIGNIFICANT ACCOUNTI_2

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Basis of Presentation (Policies)	3 Months Ended
	Mar. 31, 2024
Policies
Basis of Presentation	Basis of Presentation The accompanying condensed financial statements and related notes include the activity of the Company and have been prepared in accordance with U.S. GAAP and with the rules and regulations of the SEC to Form 10-K and 10-Q.

NOTE 2 - SIGNIFICANT ACCOUNTI_3

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Accounting Method (Policies)	3 Months Ended
	Mar. 31, 2024
Policies
Accounting Method	Accounting Method The Company’s condensed financial statements are prepared using the accrual method of accounting. The Company has elected a December 31 year-end.

NOTE 2 - SIGNIFICANT ACCOUNTI_4

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Use of Estimates (Policies)	3 Months Ended
	Mar. 31, 2024
Policies
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

NOTE 2 - SIGNIFICANT ACCOUNTI_5

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Cash and Cash Equivalents (Policies)	3 Months Ended
	Mar. 31, 2024
Policies
Cash and Cash Equivalents	Cash and Cash Equivalents We maintain cash balances in non-interest-bearing accounts, which do not currently exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents.

NOTE 2 - SIGNIFICANT ACCOUNTI_6

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Basic and Diluted Income (Loss) Per Share (Policies)	3 Months Ended
	Mar. 31, 2024
Policies
Basic and Diluted Income (Loss) Per Share	Basic and Diluted Loss Per Share The computations of basic loss per share of common stock are based on the weighted average number of shares outstanding at the date of the financial statements. The Company computes net loss per share in accordance with ASC 260, “ Earnings Per Share

NOTE 2 - SIGNIFICANT ACCOUNTI_7

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Stock-Based Compensation (Policies)	3 Months Ended
	Mar. 31, 2024
Policies
Stock-Based Compensation	Stock-Based Compensation The Company adopted ASC 718, “Stock Compensation” values beginning in the period they are granted and amortized over the applicable vesting period. As of September 30, 2023, the Company has not issued any employer stock options.

NOTE 2 - SIGNIFICANT ACCOUNTI_8

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Fair Value of Financial Instruments (Policies)	3 Months Ended
	Mar. 31, 2024
Policies
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company adopted ASC 820, “ Fair Value Measurement The Company currently does not have non-financial assets or non-financial liabilities that are required to be measured at fair value on a recurring basis.

NOTE 4 - RELATED PARTY TRANSA_2

NOTE 4 - RELATED PARTY TRANSACTIONS (Details) - USD ($)	3 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Loans or advances from related party	$ 100,319	$ 98,319
Notes Payable - Related Parties
Related Party Transaction, Description of Transaction	During the three months ended March 31, 2024, the Company received $2,000 in additional cash loans from Ronald R. Howell.
Increase (Decrease) in Due to Related Parties	$ 2,000
Related Party Transaction, Terms and Manner of Settlement	As part of the reorganization on April 24, 2024, Mr. Howell cancelled all outstanding debt obligations owed to him which was a total of $624,808, including the notes payable referenced above. See “Change of Control”.
Executive Offices
Related Party Transaction, Description of Transaction	The Company’s executive offices were located at 150 Research Dr., Hampton VA. These offices were leased by The Health Network, Inc. (“THN”), of which Ron Howell is President.
Howell Consulting Agreement
Related Party Transaction, Description of Transaction	The Company entered into a consulting agreement with Mr. Howell, President of the Company, whereby the Company agreed to pay Mr. Howell $10,000 per month for consulting services through December 31, 2010. The Company had agreed to continue to engage Mr. Howell as a consultant until his consulting services are no longer required.
Related Party Transaction, Terms and Manner of Settlement	As part of the reorganization on April 24, 2024, Mr. Howell cancelled all outstanding debt obligations owed to him which was a total of $624,808, including the amounts and accumulated interest due under the consulting agreement referenced above. See “Change of Control”.
Loans or advances from related party		$ 510,000

NOTE 5 - SUBSEQUENT EVENTS (Det

NOTE 5 - SUBSEQUENT EVENTS (Details)	3 Months Ended
	Mar. 31, 2024
Reorganization Agreement
Subsequent Event, Description	On April 24, 2024, HST Global, Inc., a Nevada Corporation (the “Company”) entered into a Reorganization and Stock Purchase Agreement (the “Reorganization Agreement”) by and among HP Auto Fund LLP (“HPAF”), HST Global Holdings, LLC (“HGHI”), Ron Howell (“Howell”) and The Health Network, Inc. (“Health Network”). Howell and Health Network were the principal shareholders of the Company. Effective April 26, 2024, the parties closed the Reorganization Agreement. As part of the transaction, Howell and Health Network, the then majority shareholders of the Company (the “the Company Shareholders”) delivered 1,634,738 shares of common stock of the Company to each of HPAF and HGHI. In addition, the Company issued to each of HPAF and HGHI 18,156,322 shares of newly-issued common stock, which, together with the transferred shares, represented approximately 95% of the outstanding equity of the Company. Further, as part of the transaction, Howell agreed to cancel $624,808 in debt obligations previously owed to Howell. As a consequence, immediately subsequent to the close of the Reorganization Agreement, the Company has 41,561,226 shares of common stock outstanding. Also as part of the reorganization, the Company will undertake a 1 for 10 reverse stock split of its outstanding shares effective upon approval by FINRA.
Subsequent Event, Date	Apr. 24, 2024
Election of Directors
Subsequent Event, Description	Effective April 26, 2024 HSTC announced the appointment of Mike Field and Jason Murphy as Directors of the Company.
Subsequent Event, Date	Apr. 26, 2024
Appointment of Officers
Subsequent Event, Description	Subsequently, the Directors appointed Mike Field as President and Acting CFO and Jason Murphy as CEO, Vice President and Secretary.